دورية أكاديمية

Effect of Aggressive Experience in Female Syrian Hamsters on Glutamate Receptor Expression in the Nucleus Accumbens.

التفاصيل البيبلوغرافية
العنوان: Effect of Aggressive Experience in Female Syrian Hamsters on Glutamate Receptor Expression in the Nucleus Accumbens.
المؤلفون: Borland JM; Department of Neuroscience, University of Minnesota, Minneapolis, MN, United States., Kim E; Department of Neuroscience, University of Minnesota, Minneapolis, MN, United States., Swanson SP; Department of Neuroscience, University of Minnesota, Minneapolis, MN, United States., Rothwell PE; Department of Neuroscience, University of Minnesota, Minneapolis, MN, United States., Mermelstein PG; Department of Neuroscience, University of Minnesota, Minneapolis, MN, United States., Meisel RL; Department of Neuroscience, University of Minnesota, Minneapolis, MN, United States.
المصدر: Frontiers in behavioral neuroscience [Front Behav Neurosci] 2020 Nov 23; Vol. 14, pp. 583395. Date of Electronic Publication: 2020 Nov 23 (Print Publication: 2020).
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101477952 Publication Model: eCollection Cited Medium: Print ISSN: 1662-5153 (Print) Linking ISSN: 16625153 NLM ISO Abbreviation: Front Behav Neurosci Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Lausanne, Switzerland : Frontiers Research Foundation, 2007-
مستخلص: Our social relationships determine our health and well-being. In rodent models, there is now strong support for the rewarding properties of aggressive or assertive behaviors to be critical for the expression and development of adaptive social relationships, buffering from stress and protecting from the development of psychiatric disorders such as depression. However, due to the false belief that aggression is not a part of the normal repertoire of social behaviors displayed by females, almost nothing is known about the neural mechanisms mediating the rewarding properties of aggression in half the population. In the following study, using Syrian hamsters as a well-validated and translational model of female aggression, we investigated the effects of aggressive experience on the expression of markers of postsynaptic structure (PSD-95, Caskin I) and excitatory synaptic transmission (GluA1, GluA2, GluA4, NR2A, NR2B, mGluR1a, and mGluR5) in the nucleus accumbens (NAc), caudate putamen and prefrontal cortex. Aggressive experience resulted in an increase in PSD-95, GluA1 and the dimer form of mGluR5 specifically in the NAc 24 h following aggressive experience. There was also an increase in the dimer form of mGluR1a 1 week following aggressive experience. Aggressive experience also resulted in an increase in the strength of the association between these postsynaptic proteins and glutamate receptors, supporting a common mechanism of action. In addition, 1 week following aggressive experience there was a positive correlation between the monomer of mGluR5 and multiple AMPAR and NMDAR subunits. In conclusion, we provide evidence that aggressive experience in females results in an increase in the expression of postsynaptic density, AMPARs and group I metabotropic glutamate receptors, and an increase in the strength of the association between postsynaptic proteins and glutamate receptors. This suggests that aggressive experience may result in an increase in excitatory synaptic transmission in the NAc, potentially encoding the rewarding and behavioral effects of aggressive interactions.
(Copyright © 2020 Borland, Kim, Swanson, Rothwell, Mermelstein and Meisel.)
References: Eur J Neurosci. 2019 Aug;50(3):2623-2634. (PMID: 30276890)
Curr Top Dev Biol. 2006;74:177-99. (PMID: 16860668)
PLoS One. 2016 Sep 12;11(9):e0162755. (PMID: 27618534)
Neuropsychopharmacology. 2018 Sep;43(10):2075-2082. (PMID: 29654259)
Neuroscience. 2018 Aug 1;384:340-349. (PMID: 29885524)
Nat Neurosci. 2018 Nov;21(11):1520-1529. (PMID: 30323276)
Behav Brain Res. 2014 Aug 15;270:277-86. (PMID: 24875769)
J Neurosci. 2008 Oct 8;28(41):10272-7. (PMID: 18842886)
Physiol Behav. 2017 Aug 1;177:264-269. (PMID: 28511867)
Neuron. 2018 Jun 27;98(6):1080-1098. (PMID: 29953871)
Sci Rep. 2016 Oct 10;6:34391. (PMID: 27721389)
Evol Psychol. 2013 Mar 20;11(1):248-62. (PMID: 23531810)
J Neurosci. 2007 Jul 25;27(30):7921-8. (PMID: 17652583)
Science. 2020 May 22;368(6493):. (PMID: 32439765)
Neuropsychopharmacology. 2018 Jan;43(2):272-284. (PMID: 28462942)
Genes Brain Behav. 2010 Oct;9(7):831-40. (PMID: 20618447)
Neuron. 2014 Apr 16;82(2):430-43. (PMID: 24742464)
Curr Opin Psychol. 2018 Feb;19:39-42. (PMID: 29279220)
Neuropsychopharmacology. 2019 Jan;44(1):97-110. (PMID: 29968846)
Nat Neurosci. 2004 Oct;7(10):1048-54. (PMID: 15452576)
Physiol Behav. 1994 Nov;56(5):1115-8. (PMID: 7824580)
Neuropharmacology. 2019 Sep 15;156:107451. (PMID: 30502376)
J Neurosci Methods. 2017 Aug 1;287:80-88. (PMID: 28587895)
J Neurophysiol. 2016 Jun 1;115(6):2989-96. (PMID: 26961102)
Child Abuse Negl. 2014 Jun;38(6):1041-50. (PMID: 24411982)
J Neurosci. 2007 May 16;27(20):5338-48. (PMID: 17507556)
J Affect Disord. 2017 Aug 15;218:131-152. (PMID: 28472703)
Science. 2016 Nov 25;354(6315):1041-1045. (PMID: 27885030)
Dialogues Clin Neurosci. 2013 Mar;15(1):11-27. (PMID: 23576886)
Front Behav Neurosci. 2010 May 28;4:22. (PMID: 20577590)
Hippocampus. 2015 Apr;25(4):474-85. (PMID: 25348768)
Hippocampus. 2006;16(11):907-15. (PMID: 17024679)
J Neurosci. 2019 Mar 27;39(13):2482-2496. (PMID: 30655356)
Proc Natl Acad Sci U S A. 2020 Jun 23;117(25):14503-14511. (PMID: 32513712)
J Cell Sci. 2009 Apr 15;122(Pt 8):1211-9. (PMID: 19339553)
Proc Natl Acad Sci U S A. 2018 Jan 30;115(5):1111-1116. (PMID: 29339486)
Genes Brain Behav. 2009 Jun;8(4):442-9. (PMID: 19566711)
Proc Natl Acad Sci U S A. 2018 Jan 9;115(2):245-253. (PMID: 29279379)
Neuropsychopharmacology. 2019 Mar;44(4):785-792. (PMID: 30467338)
Primates. 2002 Jul;43(3):191-9. (PMID: 12145400)
Psychopharmacology (Berl). 2008 Apr;197(3):449-56. (PMID: 18193405)
Mol Psychiatry. 1996 Jul;1(3):186-9. (PMID: 9118342)
Behav Biol. 1972 Jun;7(3):349-57. (PMID: 5063900)
Zoo Biol. 2007 Sep;26(5):345-61. (PMID: 19360585)
Physiol Behav. 1988;43(1):1-7. (PMID: 3413239)
Soc Cogn Affect Neurosci. 2019 Aug 31;14(8):861-870. (PMID: 31506672)
ACS Chem Neurosci. 2018 Sep 19;9(9):2114-2126. (PMID: 29280617)
Nature. 2019 May;569(7754):116-120. (PMID: 30944474)
Sci Rep. 2019 Nov 14;9(1):16843. (PMID: 31727973)
Neuroscience. 2015 Oct 29;307:117-27. (PMID: 26318330)
Front Neurosci. 2018 Nov 20;12:855. (PMID: 30515075)
Dev Cogn Neurosci. 2011 Oct;1(4):444-58. (PMID: 22436566)
Nature. 2013 Sep 12;501(7466):179-84. (PMID: 24025838)
Neuropharmacology. 2016 Aug;107:122-130. (PMID: 26946431)
Comp Biochem Physiol C Pharmacol Toxicol Endocrinol. 1998 Jun;119(3):261-74. (PMID: 9826999)
Curr Opin Psychiatry. 2013 Sep;26(5):464-7. (PMID: 23867661)
Nat Rev Neurosci. 2007 Jul;8(7):536-46. (PMID: 17585306)
J Neurosci. 2019 May 22;39(21):3996-4008. (PMID: 30833504)
Int J Mol Sci. 2019 Mar 20;20(6):. (PMID: 30897826)
Annu Rev Neurosci. 2002;25:103-26. (PMID: 12052905)
Front Behav Neurosci. 2019 Aug 07;13:178. (PMID: 31447659)
PLoS One. 2012;7(4):e34700. (PMID: 22529926)
Proc Natl Acad Sci U S A. 2020 Oct 13;117(41):25789-25799. (PMID: 32973099)
Brain Struct Funct. 2015 Jul;220(4):2415-22. (PMID: 24878822)
J Neurochem. 1999 Jun;72(6):2539-47. (PMID: 10349865)
Horm Behav. 2012 Mar;61(3):283-92. (PMID: 22079778)
Front Endocrinol (Lausanne). 2017 Nov 14;8:308. (PMID: 29184535)
Neuropharmacology. 2016 Dec;111:231-241. (PMID: 27622930)
Schizophr Res. 2020 Aug;222:304-318. (PMID: 32439293)
Front Mol Neurosci. 2012 Jun 27;5:72. (PMID: 22754497)
Horm Behav. 2003 Sep;44(3):293-9. (PMID: 14609551)
Adv Genet. 2011;75:7-22. (PMID: 22078475)
Front Behav Neurosci. 2009 Sep 07;3:13. (PMID: 19826615)
Biol Psychiatry. 2017 Aug 15;82(4):239-248. (PMID: 28434654)
Horm Behav. 1974 Dec;5(4):355-66. (PMID: 4477152)
Am J Psychiatry. 2008 Apr;165(4):429-42. (PMID: 18346997)
Biol Psychiatry. 2014 Aug 15;76(4):281-8. (PMID: 24183103)
J Neurosci. 2013 Nov 20;33(47):18381-95. (PMID: 24259563)
Trends Neurosci. 2003 Jul;26(7):360-8. (PMID: 12850432)
Biol Psychiatry. 2016 Apr 15;79(8):685-92. (PMID: 26342498)
Neurochem Res. 2019 Mar;44(3):562-571. (PMID: 28856535)
Biol Rev Camb Philos Soc. 2011 May;86(2):341-66. (PMID: 20636474)
Front Psychol. 2016 May 06;7:666. (PMID: 27199879)
Front Behav Neurosci. 2019 Oct 04;13:227. (PMID: 31636548)
Genes Brain Behav. 2013 Aug;12(6):666-72. (PMID: 23790091)
Brain Behav. 2019 Dec;9(12):e01464. (PMID: 31743626)
J Neurosci. 1992 Nov;12(11):4372-80. (PMID: 1432099)
Nat Rev Neurol. 2016 Jan;12(1):28-39. (PMID: 26670297)
Nature. 2019 Jun;570(7759):65-70. (PMID: 31118513)
Anim Behav. 1973 Aug;21(3):564-70. (PMID: 4795936)
J Neurosci. 2019 Aug 21;39(34):6610-6612. (PMID: 31434715)
Psychopharmacology (Berl). 2005 Oct;182(1):116-27. (PMID: 16133129)
J Neurosci. 2007 Aug 29;27(35):9294-300. (PMID: 17728443)
J Neurochem. 2016 May;137(3):312-30. (PMID: 26849493)
Neuroscience. 2012 Dec 27;227:163-9. (PMID: 23041760)
Eur J Neurosci. 2013 Jul;38(2):2308-18. (PMID: 23607682)
Stress. 2017 Jul;20(4):404-418. (PMID: 28554247)
Nature. 2018 Aug;560(7720):589-594. (PMID: 30089910)
Front Pharmacol. 2012 Oct 12;3:182. (PMID: 23091460)
Horm Behav. 1988 Dec;22(4):453-66. (PMID: 3235062)
J Neurosci. 2004 Sep 8;24(36):7821-8. (PMID: 15356193)
J Neurosci. 2013 Feb 20;33(8):3434-42. (PMID: 23426671)
Ann N Y Acad Sci. 2003 Nov;1003:1-11. (PMID: 14684431)
Science. 1997 Mar 14;275(5306):1593-9. (PMID: 9054347)
Proc Natl Acad Sci U S A. 2016 Nov 15;113(46):13233-13238. (PMID: 27807133)
Neurosci Biobehav Rev. 2017 Dec;83:356-372. (PMID: 29108963)
PLoS Comput Biol. 2015 Dec 04;11(12):e1004559. (PMID: 26636753)
Biol Psychiatry. 2017 Apr 15;81(8):645-653. (PMID: 27871668)
Behav Brain Res. 2015 Jun 1;286:22-8. (PMID: 25721736)
Brain Struct Funct. 2014 Nov;219(6):2071-81. (PMID: 23934655)
Proteomics. 2016 Oct;16(20):2698-2705. (PMID: 27392515)
Neuron. 2018 Oct 24;100(2):314-329. (PMID: 30359599)
Neuropharmacology. 2007 Jan;52(1):60-70. (PMID: 16904707)
Psychopharmacology (Berl). 2012 May;221(2):317-27. (PMID: 22147259)
J Neurosci. 2018 Jun 27;38(26):5913-5924. (PMID: 29891732)
Endocrinology. 2010 May;151(5):2276-86. (PMID: 20228171)
Neuropharmacology. 2017 Jan;112(Pt A):46-56. (PMID: 27157711)
معلومات مُعتمدة: R01 DA048946 United States DA NIDA NIH HHS; T32 DA007234 United States DA NIDA NIH HHS
فهرسة مساهمة: Keywords: female aggression; metabotropic Glu receptors; nucleus accumbens; social behavior; synaptic plasiticty
تواريخ الأحداث: Date Created: 20201217 Latest Revision: 20240501
رمز التحديث: 20240501
مُعرف محوري في PubMed: PMC7719767
DOI: 10.3389/fnbeh.2020.583395
PMID: 33328919
قاعدة البيانات: MEDLINE
الوصف
تدمد:1662-5153
DOI:10.3389/fnbeh.2020.583395